These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24521833)

  • 21. Evaluation of the impact of timing of pegfilgrastim administration on incidence of febrile neutropenia in elderly patients with B-cell non-Hodgkin lymphomas receiving R-CHOP-21.
    Lei MM; Watson AN; Abramson JS
    Leuk Lymphoma; 2020 Dec; 61(12):2998-3001. PubMed ID: 32686543
    [No Abstract]   [Full Text] [Related]  

  • 22. Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practice.
    Krzemieniecki K; Sevelda P; Erdkamp F; Smakal M; Schwenkglenks M; Puertas J; Trojan A; Szabo Z; Bendall K; Maenpaa J
    Support Care Cancer; 2014 Mar; 22(3):667-77. PubMed ID: 24154740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience.
    Cerchione C; De Renzo A; Di Perna M; Della Pepa R; Pugliese N; Catalano L; Pane F; Picardi M
    Support Care Cancer; 2017 Mar; 25(3):839-845. PubMed ID: 27812763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancer.
    Leung M; Florendo J; Kano J; Marr-Del Monte T; Higgins B; Myers R; Menon T; Jones G
    Support Care Cancer; 2015 Jun; 23(6):1669-77. PubMed ID: 25421443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost comparison of outpatient treatment with granulocyte colony-stimulating factors (G-CSF) in Germany.
    Hadji P; Kostev K; Schröder-Bernhardi D; Ziller V
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):281-9. PubMed ID: 22456299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conditions of isolation and purification from inclusion body].
    Kononova NV; Iakovlev AV; Zhuravko AM; Pankeev NN; Minaev SV; Bobruskin AI; Mart'ianov VA
    Bioorg Khim; 2014; 40(5):550-9. PubMed ID: 25895350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the safety and effectiveness of PegaGen
    Jenabian A; Ehsanpour A; Mortazavizadeh SMR; Raafat J; Razavi M; Khosravi A; Seifi S; Salimi B; Anjidani N; Kafi H
    Support Care Cancer; 2022 Oct; 30(10):8151-8158. PubMed ID: 35792924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antineoplastic drug-induced neutropenia: use of granulocyte colony stimulating factors].
    Carrato A; Guillén-Ponce C; Grande-Pulido E
    Farm Hosp; 2010 Mar; 34 Suppl 1():8-11. PubMed ID: 20920851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study.
    Brito M; Esteves S; André R; Isidoro M; Moreira A
    Support Care Cancer; 2016 Feb; 24(2):597-603. PubMed ID: 26111956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim.
    Kang KW; Lee BH; Jeon MJ; Yu ES; Kim DS; Lee SR; Sung HJ; Choi CW; Park Y; Kim BS
    Cancer Med; 2020 Sep; 9(17):6102-6110. PubMed ID: 32633471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colony stimulating factors: G-CSFs--filgrastim (Neupogen) and lenograstim (Granocyte).
    MacConnachie AM
    Intensive Crit Care Nurs; 1998 Feb; 14(1):49-50. PubMed ID: 9652261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pegfilgrastim on febrile neutropenia in pediatric and adolescent cancer patients: a systematic review and meta-analysis.
    Zhu X; Zhang W; Zhang Y; Wang Y; Hu H; Li J; Zhou Y; Han T; Huang D
    Hematology; 2023 Dec; 28(1):2172292. PubMed ID: 36719297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of available clinical evidence - filgrastim compared with lenograstim.
    Sourgens H; Lefrère F
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):510-8. PubMed ID: 21781651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis.
    Cooper KL; Madan J; Whyte S; Stevenson MD; Akehurst RL
    BMC Cancer; 2011 Sep; 11():404. PubMed ID: 21943360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-CSF: filgrastim, lenograstim and biosimilars.
    Welte K
    Expert Opin Biol Ther; 2014 Jul; 14(7):983-93. PubMed ID: 24707817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
    Schippinger W; Holub R; Dandachi N; Bauernhofer T; Samonigg H
    Oncology; 2006; 70(4):290-3. PubMed ID: 16899982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data.
    Gunzer K; Clarisse B; Lheureux S; Delcambre C; Joly F
    Expert Opin Biol Ther; 2010 Apr; 10(4):615-30. PubMed ID: 20218922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction: pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia.
    Petros WP
    Pharmacotherapy; 2003 Aug; 23(8 Pt 2):1S-2S; quiz 20S-23S. PubMed ID: 12921215
    [No Abstract]   [Full Text] [Related]  

  • 39. Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.
    Lambertini M; Ferreira AR; Del Mastro L; Danesi R; Pronzato P
    Expert Opin Biol Ther; 2015; 15(12):1799-817. PubMed ID: 26488491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegfilgrastim.
    Willis F; Pettengell R
    Expert Opin Biol Ther; 2002 Dec; 2(8):985-92. PubMed ID: 12517276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.